Global benchmarking report recognizes the most capable CDMOs in the ADC sector across innovation, growth, and end-to-end service excellence SAN DIEGO, March 17, 2026 /PRNewswire/ — Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, today announced it…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
